Harvoni ledipasvir regulatory update

FDA approved sNDAs from Gilead for Harvoni ledipasvir/sofosbuvir to treat patients with HCV genotypes 4-6 infection and patients co-infected with HIV. The agency also approved Harvoni in combination w...